Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients

Review of Diabetic Studies

Volumn 8, Issue 2, 2011, Pages 254-258

  Matejko, Bartlomiej ^a   Cyganek, Katarzyna ^b   Katra, Barbara ^b   Galicka Latala, Danuta ^a,b   Grzanka, Malgorzata ^a   Malecki, Maciej T ^a,b   Klupa, Tomasz ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Bolus wizard; Dual wave bolus; Glycemic control; HbA1c; Insulin pump; Monitoring; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE;

EID: 83455181401     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2011.8.254     Document Type: Article

References (22)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993. 329(14):977-986.
2. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011. In press.
3. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002. 25(3):593-598.
4. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, et al. 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 2006. 23(2):141-147.
5. Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev 2009. 25(2):99-111.
6. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010. 1:CD005103.
7. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. BMJ 1978. 1(6107):204-207.
8. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979. 300(11):573-578.
9. Wolpert H, Block J. Hands-on demonstration and discussion of new pump software/hardware. Diabetes Technol Ther 2005. 7(5):840-844.
10. Klupa T, Benbenek-Klupa T, Malecki M, Szalecki M, Sieradzki J. Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. J Int Med Res 2008. 36(5):1112-1116.
11. Shashaj B, Busetto E, Sulli N. Benefits of a bolus calculator in pre-and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). Diabet Med 2008. 25(9):1036-1042.
12. Cukierman-Yaffe T, Konvalina N, Cohen O. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Diabetes Res Clin Pract 2011. 92(1):69-73.
13. Herman WH, IIag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005. 28(8):1568-1573.
14. Rizvi AA, Petry R, Arnold MB, Chakraborty M. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract 2001. 7(5):364-369.
15. Lepore G, Dodesini AR, Nosari I, Trevisan R. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients. Diabetes Care 2005. 28(7):1834-1835.
16. Hanaire H, Lassmann-Vague V, Jeandidier N, Renard E, Tubiana-Rufi N, Vambergue A, Raccah D, Pinget M, Guerci B. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008. 34(4):401-423.
17. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002. 25(3):593-598.
18. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 2002. 111(5):69-77.
19. Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW. for the German/Austrian DPV Initiative, the German Pediatric CSII Working Group and the BMBF Competence Network Diabetes. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 2011. In press.
20. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997. 30(5):1144-1149.
21. Brown DR, Yore MM, Ham SA, Macera CA. Physical activity among adults > or =50 yr with and without disabilities, BRFSS 2001. Med Sci Sports Exerc 2005. 37(4):620-629.
22. Klupa T, Matejko B, Cyganek K, Katra B, Galicka-Latała D, Grzanka M, Malecki MT. Insulin pump therapy may be equally effective in elderly an young type 1 diabetes patients. Diabetologia 2011 54(Suppl 1):P976.